Treatment with BGA002 showed a marked reduction in all neuroblastoma cell lines, and combined treatment with RA further strengthened MYCN inhibition (Fig. 1A) in a dose-dependent manner (Supplementary Fig. S1A). This evidence concerns the gene MYCN and neuroblastoma.